Skip to main content

Ventyx Biosciences, Inc.

corporate_fare Company Profile

Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for Crohn's disease. It is also developing Tamuzimod, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor that is in Phase 2a trial for patients with early Parkinson's disease and is in Phase 2 trial for patients with obesity and additional risk factors for cardiovascular disease. Ventyx Biosciences, Inc. was incorporated in 2018 and is headquartered in San Diego, California.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed VTYX - Latest Insights

VTYX
Mar 05, 2026, 9:00 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
VTYX
Mar 04, 2026, 9:22 AM EST
Filing Type: 8-K
Importance Score:
10
VTYX
Mar 03, 2026, 5:02 PM EST
Filing Type: 8-K
Importance Score:
8
VTYX
Feb 23, 2026, 4:29 PM EST
Filing Type: DEFA14A
Importance Score:
7
VTYX
Feb 23, 2026, 4:26 PM EST
Filing Type: 8-K
Importance Score:
8
VTYX
Feb 02, 2026, 4:05 PM EST
Filing Type: DEFM14A
Importance Score:
8
VTYX
Jan 22, 2026, 5:29 PM EST
Filing Type: PREM14A
Importance Score:
7
VTYX
Jan 22, 2026, 4:18 PM EST
Filing Type: DEFA14A
Importance Score:
7
VTYX
Jan 22, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
10
VTYX
Jan 09, 2026, 9:48 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
10
VTYX
Jan 09, 2026, 9:48 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
10
VTYX
Jan 07, 2026, 9:30 PM EST
Filing Type: DEFA14A
Importance Score:
10
VTYX
Jan 07, 2026, 9:29 PM EST
Filing Type: DEFA14A
Importance Score:
10
VTYX
Jan 07, 2026, 9:28 PM EST
Filing Type: DEFA14A
Importance Score:
10
VTYX
Jan 07, 2026, 9:27 PM EST
Filing Type: DEFA14A
Importance Score:
10
VTYX
Jan 07, 2026, 9:26 PM EST
Filing Type: DEFA14A
Importance Score:
10
VTYX
Jan 07, 2026, 9:26 PM EST
Filing Type: DEFA14A
Importance Score:
10
VTYX
Jan 07, 2026, 9:24 PM EST
Filing Type: DEFA14A
Importance Score:
10
VTYX
Jan 07, 2026, 9:22 PM EST
Filing Type: DEFA14A
Importance Score:
10
VTYX
Jan 07, 2026, 5:04 PM EST
Filing Type: DEFA14A
Importance Score:
10